The anti-inflammatory effects of HMGB1 blockades, including anti-HMGB1 monoclonal antibody and glycyrrhizin, have been shown in a mouse model of cutaneous vasculitis [100]. Here, HMGB1 is linked to cutaneous vasculitis.